Viewing Study NCT02106858


Ignite Creation Date: 2025-12-25 @ 12:00 AM
Ignite Modification Date: 2026-01-24 @ 2:34 PM
Study NCT ID: NCT02106858
Status: COMPLETED
Last Update Posted: 2023-07-24
First Post: 2014-04-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Stivarga Regulatory Post-Marketing Surveillance Study in Korea
Sponsor: Bayer
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2014-06-25
Start Date Type: ACTUAL
Primary Completion Date: 2019-05-07
Primary Completion Date Type: ACTUAL
Completion Date: 2019-05-07
Completion Date Type: ACTUAL
First Submit Date: 2014-04-04
First Submit QC Date: None
Study First Post Date: 2014-04-08
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-07-20
Last Update Post Date: 2023-07-24
Last Update Post Date Type: ACTUAL